Jacobson Pharma Announces FY2025 Annual Results
Jun 13, 2025 19:16 HKT/SGT
- Profit from Continuing Operations Surges 43.1% to HK$300.8 million
- Sustained Momentum by Capturing Healthcare Trends
- Solid Financial Strength to Fuel Future Growth
- Sustained Momentum by Capturing Healthcare Trends
- Solid Financial Strength to Fuel Future Growth